Jazz Pharmaceuticals plc — Director's Dealing 2014

Dec 11, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-12-09

Reporting Person: Hooper Suzanne Sawochka (EVP and General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-09	Ordinary Shares	M	1347	$46.83	Acquired	49647	Direct
2014-12-09	Ordinary Shares	S	1852	$178.79	Disposed	47795	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-12-09	Nonstatutory Stock Option (right to buy)	$46.83	M	1347	Disposed	2022-08-08	Ordinary Shares (1347)	Direct

Footnotes

F1: Includes 51 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 28, 2014.

F2: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3: As of the date of this report, the remaining ordinary shares subject to this option are vested with respect to 29,361 shares and will vest with respect to 15,365 shares in equal monthly installments from January 9, 2015 to December 9, 2015 and with respect to 9,532 shares in equal monthly installments from January 9, 2016 to August 9, 2016.